---
title: "__NewInstitute__ Quality Manual"
subtitle: "SOP-005: Study Design Review Procedure"
---

## 1.0 PURPOSE

This Standard Operating Procedure (SOP) establishes the formal review and
approval process for *observational studies* designs developed by __NewInstitute__.
It ensures that study designs are systematically evaluated against scientific,
ethical, regulatory, operational, and quality requirements at defined decision
gates.

## 2.0 SCOPE

This procedure applies to all formal review and approval of design activities of
*observational studies* at __NewInstitute__.

This procedure defines:

- **When** design reviews occur (review gates aligned with SOP-001 design phases)
- **What** is evaluated at each review (review criteria)
- **Who** participates in reviews (review perspectives and approval authorities)
- **How** reviews are conducted and documented (review process)

This procedure works in conjunction with [SOP-001: Design Controls
Procedure](SOP-001--Design_Controls_Procedure.md), which defines the
development of study designs and design deliverables. SOP-001 specifies *what*
to create; this procedure specifies *how* to review and approve those
deliverables.

Reviews of changes to approved and active studies are conducted according to
this procedure, while the change process itself is managed under
[SOP-013: Change Control Procedure](SOP-013--Change_Control_Procedure.md).

## 3.0 REFERENCES, TERMS AND ACRONYMS

### 3.1 Guidance and Regulatory References

- [ICH E6(R2)](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r2-good-clinical-practice-integrated-addendum-ich-e6r1):
  Good Clinical Practice: Integrated Addendum to ICH E6(R1)

- [ICH E8(R1)](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e8r1-general-considerations-clinical-studies):
  General Considerations for Clinical Studies - Section 3 (Designing Quality
  into Clinical Studies), Section 7 (Considerations in Identifying Critical to
  Quality Factors)

- [ICH E9](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e9-statistical-principles-clinical-trials):
  Statistical Principles for Clinical Trials

- [ISO 9001:2015](https://www.iso.org/standard/62085.html): Quality management
  systems â€” Requirements (Section 8.3: Design and development)
  
### 3.2 __NewInstitute__ References 

1. [QM-001: Quality Manual](QM-001--QualityManual.md)

2. [SOP-001: Design Controls Procedure](SOP-001--Design_Controls_Procedure.md)

3. [SOP-002: Document and Records Controls
   Procedure](SOP-002--Document_and_Records_Controls_Procedure.md)

4. [SOP-003: Risk Management and Quality Risk Management
   Procedure](SOP-003--Risk_Management_and_Quality_Risk_Management_Procedure.md)

5. [SOP-013: Change Control Procedure](SOP-013--Change_Control_Procedure.md)

### 3.3 Terms

- **Critical-to-Quality Factor**: An attribute of a study whose integrity is
  fundamental to the protection of study participants, the reliability and
  interpretability of the study results, and the decisions made based on the
  study results. [ICH E8(R1) Section 3.2]

- **Design Review**: A systematic examination of a design to evaluate its
  adequacy, identify problems, and propose necessary actions.

- **Review Gate**: A formal decision point at which design outputs are evaluated
  and a decision is made to proceed, proceed with conditions, or halt.

- **Review Perspective**: A specific discipline or viewpoint (e.g., scientific,
  statistical, regulatory) from which design outputs are evaluated.

### 3.4 Acronyms

- **CRF**: Case Report Form
- **CtQ**: Critical to Quality
- **IRB**: Institutional Review Board
- **IEC**: Independent Ethics Committee
- **QTL**: Quality Tolerance Limit
- **SAP**: Statistical Analysis Plan
- **TMF**: Trial Master File

## 4.0 REVIEW FRAMEWORK

### 4.1 Overview

Design reviews are conducted at defined gates corresponding to the design phases
in SOP-001. Each review gate evaluates design outputs from the preceding phase
and determines readiness to proceed to the next phase.

The review framework consists of:

- **Six Review Gates**: Defined decision points aligned with SOP-001 phases
- **Eight Review Perspectives**: Disciplines contributing to design evaluation
- **Proportionate Application**: Review intensity scaled to study complexity and
  risk

### 4.2 Review Gates

The following review gates correspond to SOP-001 design phases:

| Review Gate | SOP-001 Phase | Purpose |
|-------------|---------------|---------|
| Concept Review | 5.2 Study Concept and Feasibility | Approve study concept and authorize protocol development |
| Protocol Review | 5.3 Protocol Development | Approve protocol and authorize detailed design |
| Design Output Review | 5.4 Statistical Planning + 5.5 Regulatory/Ethics | Approve design outputs and authorize verification |
| Verification Review | 5.6 Design Verification | Confirm outputs meet inputs; authorize validation |
| Validation Review | 5.7 Design Validation | Confirm fitness for purpose; authorize transfer |
| Final Design Approval | 5.8 Design Transfer | Authorize study initiation |

### 4.3 Review Perspectives

Design reviews incorporate input from multiple perspectives to ensure
comprehensive evaluation. The following perspectives are defined:

| Perspective | Focus Areas |
|-------------|-------------|
| Scientific | Research question, study objectives, scientific rationale, study design, endpoints, population |
| Statistical | Sample size, statistical methods, estimands, analysis plan, power, multiplicity |
| Operational | Feasibility, resources, timeline, site capabilities, recruitment, retention |
| Regulatory | Regulatory requirements, submissions, compliance, applicable guidance |
| Ethics | Subject protection, informed consent, IRB/IEC requirements, vulnerable populations |
| Quality | GCP compliance, data integrity, documentation, risk management, QMS alignment |
| Data Management | Data collection, CRFs, database design, data flow, validation rules, ALCOA+ |
| Safety | Subject safety, adverse event procedures, stopping rules, safety monitoring |

Not all perspectives are required at every review gate. Section 5.0 specifies
which perspectives apply at each gate. Additional perspectives may be included
based on study-specific needs.

### 4.4 Proportionate Application

Per ICH E8(R1) Section 3.2, review intensity **SHALL** be proportionate to:

- Study complexity and novelty
- Risk to subject safety and data integrity
- Regulatory requirements and intended use of data
- Organizational experience with similar studies

For lower-risk, straightforward studies, reviews may be streamlined by:

- Combining review gates where appropriate
- Reducing the number of required perspectives
- Conducting reviews via document circulation rather than formal meetings

The determination of appropriate review intensity **SHALL** be documented and
justified based on risk assessment per SOP-003.

## 5.0 REVIEW GATES

### 5.1 Concept Review

#### 5.1.1 Purpose

The Concept Review evaluates the study concept and feasibility assessment to
determine whether the proposed study is scientifically sound, ethically
appropriate, and operationally feasible. Approval at this gate authorizes
proceeding to protocol development.

#### 5.1.2 Timing

The Concept Review **SHALL** be conducted after completion of design outputs
from SOP-001 Section 5.2 (Study Concept and Feasibility) and before initiating
protocol development (SOP-001 Section 5.3).

#### 5.1.3 Design Outputs to Review

The following design outputs from SOP-001 Section 5.2.5 **SHALL** be reviewed:

- Design Input Documentation (research question, objectives, scientific
  rationale, preliminary design approach, regulatory requirements, constraints)
- Feasibility Assessment (site capabilities, recruitment potential, resources,
  timeline, budget)
- Initial Risk Management Plan (critical processes and data, preliminary risk
  categories, high-level mitigation strategies)
- Investigator's Brochure or Study Information Document (if prepared)

#### 5.1.4 Required Review Perspectives

The following perspectives **SHALL** participate in Concept Review:

- Scientific
- Operational
- Quality

Additional perspectives (Regulatory, Ethics, Safety) **MAY** be included based
on study characteristics.

#### 5.1.5 Review Criteria

<!-- BORROWED FROM SOP-001 Section 5.2.6 -->
The Concept Review **SHALL** assess:

- Scientific merit and innovation
- Alignment with organizational priorities
- Feasibility and resource availability
- Preliminary ethical and regulatory considerations
- Identified risks and mitigation strategies

Additional criteria:

- Clarity of research question and study objectives
- Appropriateness of preliminary study design for objectives
- Adequacy of feasibility assessment
- Identification of critical-to-quality factors per ICH E8(R1)
- Completeness of design input documentation

#### 5.1.6 Decision Outcomes

The Concept Review **SHALL** result in one of the following decisions:

- **Approved**: Proceed to protocol development
- **Approved with Conditions**: Proceed to protocol development after addressing
  specified conditions; conditions **SHALL** be documented and tracked
- **Revise and Re-review**: Return to concept development; re-review required
  before proceeding
- **Not Approved**: Study concept not approved; document rationale

#### 5.1.7 Approval Authority

**todo**: Define approval authority for Concept Review (e.g., Study Director,
Scientific Director, or designated review committee)

#### 5.1.8 Documentation

Records of the Concept Review **SHALL** include:

- Review date and participants
- Design outputs reviewed
- Review findings and discussion summary
- Decision outcome
- Conditions or action items (if applicable)
- Signatures of approval authority

Review records **SHALL** be included in the TMF per SOP-001 Section 5.2.6.

### 5.2 Protocol Review

#### 5.2.1 Purpose

The Protocol Review evaluates the draft protocol and associated design outputs
to determine whether the study design is scientifically valid, statistically
adequate, ethically appropriate, and operationally feasible. Approval at this
gate authorizes proceeding to detailed statistical planning, data collection
design, and regulatory/ethics documentation.

#### 5.2.2 Timing

The Protocol Review **SHALL** be conducted after completion of design outputs
from SOP-001 Section 5.3 (Protocol Development) and before initiating detailed
statistical planning (SOP-001 Section 5.4).

#### 5.2.3 Design Outputs to Review

The following design outputs from SOP-001 Section 5.3.4 **SHALL** be reviewed:

- Study Protocol (complete protocol addressing all ICH E6(R2) Section 6
  requirements)
- Protocol Synopsis (if prepared)
- Risk Management Plan (comprehensive plan per SOP-003)
- Sample Case Report Form (preliminary CRF showing data elements)
- Sample Informed Consent Form (draft addressing ICH E6(R2) Section 4.8)
- Monitoring Plan (risk-based monitoring plan per SOP-009)

#### 5.2.4 Required Review Perspectives

The following perspectives **SHALL** participate in Protocol Review:

- Scientific
- Statistical
- Operational
- Regulatory
- Ethics
- Quality

Additional perspectives (Data Management, Safety) **MAY** be included based on
study characteristics.

#### 5.2.5 Review Criteria

<!-- BORROWED FROM SOP-001 Section 5.3.6 -->
The Protocol Review **SHALL** assess:

- Scientific validity and merit
- Completeness per ICH E6(R2) Section 6 requirements
- Ethical appropriateness and subject protection
- Feasibility and operational clarity
- Statistical adequacy
- Regulatory compliance
- Risk assessment and mitigation strategies
- Consistency with design inputs
- Clarity and completeness of procedures

Additional criteria by perspective:

**Scientific:**

- Clear articulation of research question and objectives
- Appropriateness of study design for objectives
- Scientific justification for inclusion/exclusion criteria
- Appropriateness of endpoints and assessments
- Adequate background and rationale

**Statistical:**

- Appropriateness of preliminary sample size considerations
- Clarity of primary and secondary endpoints
- Statistical feasibility of study objectives
- Preliminary consideration of analysis approach

**Operational:**

- Feasibility of recruitment targets
- Adequacy of visit schedule and subject burden
- Clarity of study procedures
- Resource requirements and availability
- Timeline feasibility

**Regulatory:**

- Compliance with applicable regulations
- Appropriate regulatory pathway identified
- Adequate consideration of regulatory requirements

**Ethics:**

- Adequate subject protection measures
- Appropriate informed consent process
- Consideration of vulnerable populations (if applicable)
- Adequate risk-benefit assessment

**Quality:**

- Alignment with QMS requirements
- Adequacy of Risk Management Plan
- GCP compliance considerations
- Data integrity considerations

#### 5.2.6 Decision Outcomes

The Protocol Review **SHALL** result in one of the following decisions:

- **Approved**: Proceed to statistical planning and data collection design
- **Approved with Conditions**: Proceed after addressing specified conditions
- **Revise and Re-review**: Return to protocol development; re-review required
- **Not Approved**: Protocol not approved; document rationale

#### 5.2.7 Approval Authority

**todo**: Define approval authority for Protocol Review

#### 5.2.8 Documentation

Records of the Protocol Review **SHALL** include:

- Review date and participants (with perspectives represented)
- Design outputs reviewed (with version numbers)
- Review findings by perspective
- Discussion summary
- Decision outcome
- Conditions or action items (if applicable)
- Signatures of approval authority

Review records **SHALL** be included in the TMF per SOP-001 Section 5.3.6.

### 5.3 Design Output Review

#### 5.3.1 Purpose

The Design Output Review evaluates the detailed statistical analysis plan, data
collection design, and regulatory/ethics documentation to determine whether
design outputs are complete, technically sound, and ready for verification.
Approval at this gate authorizes proceeding to design verification.

#### 5.3.2 Timing

The Design Output Review **SHALL** be conducted after completion of design
outputs from SOP-001 Sections 5.4 (Statistical Planning and Data Collection
Design) and 5.5 (Regulatory and Ethics Documentation) and before initiating
design verification (SOP-001 Section 5.6).

#### 5.3.3 Design Outputs to Review

The following design outputs **SHALL** be reviewed:

**From SOP-001 Section 5.4.4 (Statistical Planning and Data Collection):**

- Statistical Analysis Plan (SAP)
- Sample Size Justification
- Randomization Specifications (if applicable)
- Case Report Forms (CRFs)
- Data Collection Tool Specifications
- Data Management Plan
- Data Dictionary
- Instructions for Data Collection
- Normal Values/Ranges for Laboratory and Medical Procedures
- Laboratory and Technical Procedures Documentation

**From SOP-001 Section 5.5.4 (Regulatory and Ethics Documentation):**

- Informed Consent Form(s)
- Subject Information Sheets
- Assent Forms (if applicable)
- IRB/IEC Submission Package
- IRB/IEC Composition Documentation
- Investigator CVs and Qualifications
- Training Documentation
- Delegation of Authority Log (if applicable)
- Financial Disclosure Forms
- Financial Arrangements Documentation
- Regulatory Authority Submissions (if applicable)
- Insurance Documentation (if required)
- Clinical Study Agreements

#### 5.3.4 Required Review Perspectives

The following perspectives **SHALL** participate in Design Output Review:

- Statistical
- Data Management
- Regulatory
- Ethics
- Quality

Additional perspectives (Scientific, Operational, Safety) **MAY** be included
based on study characteristics.

#### 5.3.5 Review Criteria

<!-- BORROWED FROM SOP-001 Section 5.4.6 -->
**Statistical and Data Management criteria:**

- Statistical validity and appropriateness of methods
- Adequacy of sample size and power
- Completeness and clarity of SAP per ICH E9 and E9(R1)
- Appropriateness of estimands and sensitivity analyses
- Completeness and clarity of CRFs
- Feasibility of data collection procedures
- Adequacy of data validation and quality control procedures
- Consistency between protocol, SAP, CRFs, and data collection tools
- Computer system validation status per SOP-004
- Compliance with data integrity principles (ALCOA+)
- Risk mitigation strategies for data quality

<!-- BORROWED FROM SOP-001 Section 5.5.7 -->
**Regulatory and Ethics criteria:**

- Completeness of informed consent per ICH E6(R2) Section 4.8 requirements
- Appropriateness of language and readability for target subject population
- Adequacy of investigator qualifications and training
- Completeness of financial disclosure documentation per 21 CFR Part 54
- Completeness of IRB/IEC submission package
- Compliance with regulatory requirements
- Adequacy of insurance and indemnity coverage (if required)
- Completeness of agreements between parties

#### 5.3.6 Decision Outcomes

The Design Output Review **SHALL** result in one of the following decisions:

- **Approved**: Proceed to design verification
- **Approved with Conditions**: Proceed after addressing specified conditions
- **Revise and Re-review**: Return to design development; re-review required
- **Not Approved**: Design outputs not approved; document rationale

#### 5.3.7 Approval Authority

**todo**: Define approval authority for Design Output Review

#### 5.3.8 Documentation

Records of the Design Output Review **SHALL** include:

- Review date and participants (with perspectives represented)
- Design outputs reviewed (with version numbers)
- Review findings by perspective
- Discussion summary
- Decision outcome
- Conditions or action items (if applicable)
- Signatures of approval authority

Review records **SHALL** be included in the TMF per SOP-001 Sections 5.4.6 and
5.5.7.

### 5.4 Verification Review

#### 5.4.1 Purpose

The Verification Review evaluates the results of design verification activities
to confirm that design outputs meet design input requirements ("Did we build it
right?"). Approval at this gate authorizes proceeding to design validation.

#### 5.4.2 Timing

The Verification Review **SHALL** be conducted after completion of design
verification activities (SOP-001 Section 5.6) and before initiating design
validation (SOP-001 Section 5.7).

#### 5.4.3 Design Outputs to Review

The following design outputs from SOP-001 Section 5.6.5 **SHALL** be reviewed:

- Design Verification Reports
- Protocol Review Reports (scientific, statistical, regulatory, operational)
- Statistical Review Reports
- Risk Management Plan Review Reports
- CRF Review Reports
- User Acceptance Testing Results
- Cross-Document Consistency Review
- Informed Consent Readability Assessment

#### 5.4.4 Required Review Perspectives

The following perspectives **SHALL** participate in Verification Review:

- Scientific
- Statistical
- Data Management
- Quality

Additional perspectives **MAY** be included based on study characteristics and
verification findings.

#### 5.4.5 Review Criteria

<!-- BORROWED FROM SOP-001 Section 5.6.7 -->
The Verification Review **SHALL** confirm:

- Verification activities were adequate and appropriate
- All design inputs have been addressed in design outputs
- Deficiencies have been adequately resolved
- Design is ready to proceed to validation

Additional criteria:

- Design outputs address all design input requirements
- Protocol content meets ICH E6(R2) Section 6 requirements
- Statistical methods are appropriate for study objectives and endpoints
- Sample size is adequate to address study objectives
- CRFs and data collection tools capture all required data elements
- Data management procedures ensure data quality and integrity
- Informed consent addresses all required elements per ICH E6(R2) Section 4.8
- Regulatory and ethics documentation is complete
- Risk Management Plan addresses all identified critical processes and data
- Design outputs are internally consistent (protocol, SAP, CRFs align)
- Documentation is clear, complete, and free from ambiguities
- All applicable regulatory and ethical requirements are addressed

#### 5.4.6 Decision Outcomes

The Verification Review **SHALL** result in one of the following decisions:

- **Approved**: Proceed to design validation
- **Approved with Conditions**: Proceed after addressing specified conditions
- **Revise and Re-verify**: Return to verification; re-review required
- **Not Approved**: Verification not approved; document rationale

#### 5.4.7 Approval Authority

**todo**: Define approval authority for Verification Review

#### 5.4.8 Documentation

Records of the Verification Review **SHALL** include:

- Review date and participants
- Verification reports reviewed
- Confirmation that all design inputs are addressed
- Confirmation that deficiencies are resolved
- Decision outcome
- Conditions or action items (if applicable)
- Signatures of approval authority

Review records **SHALL** be included in the TMF per SOP-001 Section 5.6.7.

### 5.5 Validation Review

#### 5.5.1 Purpose

The Validation Review evaluates the results of design validation activities to
confirm that the study design is fit for its intended purpose and capable of
meeting study objectives ("Did we build the right thing?"). Approval at this
gate authorizes proceeding to design transfer and final approval.

#### 5.5.2 Timing

The Validation Review **SHALL** be conducted after completion of design
validation activities (SOP-001 Section 5.7) and before initiating design
transfer (SOP-001 Section 5.8).

#### 5.5.3 Design Outputs to Review

The following design outputs from SOP-001 Section 5.7.5 **SHALL** be reviewed:

- Design Validation Report
- Pilot Study Results (if conducted)
- End-to-End Testing Report (if conducted)
- Site Readiness Assessment (if conducted)
- System Validation Documentation

#### 5.5.4 Required Review Perspectives

The following perspectives **SHALL** participate in Validation Review:

- Operational
- Quality
- Safety

Additional perspectives (Scientific, Statistical, Data Management) **MAY** be
included based on study characteristics and validation findings.

#### 5.5.5 Review Criteria

<!-- BORROWED FROM SOP-001 Section 5.7.7 -->
The Validation Review **SHALL** confirm:

- Validation activities were adequate for the study design and complexity
- The study design is fit for its intended purpose
- Issues have been adequately resolved or mitigated
- The study is ready to proceed to final approval and initiation

Additional criteria:

- The study design is scientifically sound and capable of meeting study
  objectives
- Study procedures are feasible and can be executed as specified in the protocol
- Data collection methods will generate data of adequate quality to support
  planned analyses
- Subject burden is acceptable and will not compromise data quality or subject
  retention
- Computerized systems function correctly in the intended use environment
- Site personnel can execute study procedures as specified
- Risk mitigation strategies defined in the Risk Management Plan are feasible
  and executable
- The overall study design will produce reliable, interpretable results

#### 5.5.6 Decision Outcomes

The Validation Review **SHALL** result in one of the following decisions:

- **Approved**: Proceed to design transfer and final approval
- **Approved with Conditions**: Proceed after addressing specified conditions
- **Revise and Re-validate**: Return to validation; re-review required
- **Not Approved**: Validation not approved; document rationale

#### 5.5.7 Approval Authority

**todo**: Define approval authority for Validation Review

#### 5.5.8 Documentation

Records of the Validation Review **SHALL** include:

- Review date and participants
- Validation reports reviewed
- Confirmation of fitness for purpose
- Confirmation that issues are resolved or mitigated
- Decision outcome
- Conditions or action items (if applicable)
- Signatures of approval authority

Review records **SHALL** be included in the TMF per SOP-001 Section 5.7.7.

### 5.6 Final Design Approval

#### 5.6.1 Purpose

The Final Design Approval is the authorization gate for study initiation. This
review confirms that all design, verification, and validation activities are
complete; all required approvals (including IRB/IEC and regulatory, if
applicable) are obtained; and the study is ready to begin. Approval at this gate
authorizes transition from Phase 1 (design) to Phase 2 (study conduct).

#### 5.6.2 Timing

The Final Design Approval **SHALL** be conducted after:

- Completion of all design outputs from SOP-001 Sections 5.2 through 5.5
- Completion of design verification (SOP-001 Section 5.6)
- Completion of design validation (SOP-001 Section 5.7)
- Receipt of IRB/IEC approval
- Receipt of regulatory authority approval (if required)
- Execution of all required agreements
- Completion of site training and readiness activities

#### 5.6.3 Design Outputs to Review

The following **SHALL** be confirmed complete and approved:

**Design Completion:**

- All design outputs from SOP-001 Sections 5.2 through 5.5 are complete and
  approved
- Risk Management Plan finalized per SOP-003 with all identified risks assessed
  and mitigation strategies defined
- Design verification activities (Section 5.6) are complete with all findings
  resolved
- Design validation activities (Section 5.7) are complete with all findings
  resolved or adequately mitigated
- All prior review gates (Concept, Protocol, Design Output, Verification,
  Validation) are complete with approved outcomes

**Regulatory and Ethics Approvals:**

- IRB/IEC approval obtained for protocol and informed consent
- Regulatory authority approval or notification complete (if required)
- All required agreements executed (sponsor-investigator agreements, CRO
  agreements, etc.)

**Site Readiness:**

- Investigator and site staff training complete
- Site facilities and equipment ready
- Source document templates and study supplies available at sites
- Data collection systems accessible and functional at sites

**Documentation Completeness:**

- Trial Master File established and organized per SOP-002
- All Phase 1 essential documents per ICH E6(R2) Section 8.2 in the TMF
- All validation and verification documentation complete

#### 5.6.4 Required Review Perspectives

All perspectives **SHALL** confirm readiness within their areas:

- Scientific
- Statistical
- Operational
- Regulatory
- Ethics
- Quality
- Data Management
- Safety

#### 5.6.5 Review Criteria

<!-- BORROWED FROM SOP-001 Section 5.8.6 -->
The Final Design Approval review **SHALL** confirm:

- All design, verification, and validation activities are complete
- All design review action items have been closed
- IRB/IEC approval is obtained and current
- Regulatory approvals are obtained (if required)
- All agreements are executed
- Sites are trained and ready to initiate
- TMF is complete with all Phase 1 essential documents
- All computerized systems are validated and ready for use
- Study team is trained and ready to conduct the study
- Monitoring plan is in place per SOP-009
- Risk mitigation strategies are documented and in place per SOP-003

#### 5.6.6 Decision Outcomes

<!-- BORROWED FROM SOP-001 Section 5.8.6 -->
The Final Design Approval review **SHALL** result in one of the following
decisions:

- **Approved**: Authorize study initiation
- **Approved with Conditions**: Authorize study initiation after addressing
  specified conditions; conditions **SHALL** be resolved before first subject
  enrollment
- **Deferred**: Defer study initiation pending resolution of identified issues
- **Not Approved**: Study initiation not approved; document rationale

#### 5.6.7 Approval Authority

**todo**: Define approval authority for Final Design Approval (e.g., Study
Director, Principal Investigator, Sponsor representative, Quality representative)

Protocol signature requirements per SOP-001 Section 5.8.3:

- Principal Investigator(s) or Study Director
- Sponsor representative (as applicable)
- Statistical lead (as applicable)
- Other parties as required by organizational policy or regulatory requirements

#### 5.6.8 Documentation

Records of the Final Design Approval **SHALL** include:

- Review date and participants
- Confirmation checklist for all required elements
- Readiness confirmation from each perspective
- Decision outcome
- Conditions or action items (if applicable)
- Signatures of all approval authorities
- Signed protocol per ICH E6(R2) 8.2.2

Review records **SHALL** be included in the TMF per SOP-001 Section 5.8.6.

## 6.0 REVIEW PROCESS

### 6.1 Review Planning

The study team **SHALL** plan reviews in advance by:

- Identifying the appropriate review gate based on design phase
- Determining required and optional review perspectives
- Scheduling review meeting or establishing review timeline
- Distributing design outputs to reviewers with adequate time for review
- Providing reviewers with relevant review criteria and checklists

### 6.2 Review Conduct

Reviews **MAY** be conducted through:

- **Formal Review Meeting**: Scheduled meeting with all required perspectives
  present; recommended for Protocol Review, Design Output Review, and Final
  Design Approval
- **Document Circulation**: Sequential or parallel review via document
  circulation with written comments; acceptable for Concept Review, Verification
  Review, and Validation Review for lower-complexity studies
- **Hybrid Approach**: Document circulation followed by meeting to resolve
  issues and reach decision

Regardless of review method:

- All required perspectives **SHALL** provide input
- Review findings **SHALL** be documented
- Decision **SHALL** be formally recorded with signatures

### 6.3 Review Findings

Review findings **SHALL** be categorized as:

- **Critical**: Must be resolved before proceeding; requires re-review
- **Major**: Must be resolved before proceeding or addressed as condition of
  approval
- **Minor**: Should be addressed but does not prevent proceeding
- **Observation**: Noted for consideration; no action required

All critical and major findings **SHALL** be tracked to resolution.

### 6.4 Action Item Management

Action items from reviews **SHALL**:

- Be clearly described with acceptance criteria
- Be assigned to responsible individuals
- Have target completion dates
- Be tracked to completion
- Be verified as adequately addressed before gate closure

### 6.5 Re-review Requirements

Re-review **SHALL** be conducted when:

- Critical findings are identified
- Decision is "Revise and Re-review"
- Significant changes are made to design outputs after initial review
- Conditions of approval are not met within specified timeframe

Re-review **MAY** be limited to affected areas if changes are isolated.

## 7.0 ROLES AND RESPONSIBILITIES

tbd

## 8.0 TRAINING

All personnel involved in design review activities **SHALL** be trained on this
procedure and maintain documented evidence of training according to [QM-001
Section 6.1.1](QM-001--QualityManual.md#611-people).

Training **SHALL** include:

- Review gate requirements and timing
- Review criteria for applicable perspectives
- Documentation requirements
- Decision-making process and escalation

Training records **SHALL** be maintained per SOP-002.

## 9.0 RECORDS

The following records **SHALL** be maintained in the TMF or QMS files:

| Record | Location | Retention |
|--------|----------|-----------|
| Concept Review documentation | TMF | Per SOP-002 |
| Protocol Review documentation | TMF | Per SOP-002 |
| Design Output Review documentation | TMF | Per SOP-002 |
| Verification Review documentation | TMF | Per SOP-002 |
| Validation Review documentation | TMF | Per SOP-002 |
| Final Design Approval documentation | TMF | Per SOP-002 |
| Signed protocol | TMF | Per SOP-002 |
| Action item logs and resolution documentation | TMF | Per SOP-002 |
| Training records | QMS files | Per SOP-002 |
